María Cristina Ballesteros-Briones

Long-Term Systemic Expression of a Novel PD-1 Blocking Nanobody from an AAV Vector Provides Antitumor Activity without Toxicity

S. Hervás-Stubbs, G. González-Sapienza, N. Casares, 2020, Biomedicines.

Optimization of a GDNF production method based on Semliki Forest virus vector.

E. Ansorena, E. Garbayo, M. Blanco-Prieto, 2021, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Capsid-deficient alphaviruses generate propagative infectious microvesicles at the plasma membrane

J. Prieto, N. Abrescia, C. Smerdou, 2016, Cellular and Molecular Life Sciences.

Idiotype vaccines produced with a non-cytopathic alphavirus self-amplifying RNA vector induce antitumor responses in a murine model of B-cell lymphoma

C. Smerdou, Noelia Silva-Pilipich, E. Martišová, 2021, Scientific Reports.

Adenovirus-Mediated Inducible Expression of a PD-L1 Blocking Antibody in Combination with Macrophage Depletion Improves Survival in a Mouse Model of Peritoneal Carcinomatosis

M. Buñuales, S. Hervás-Stubbs, S. Lumbreras, 2021, International journal of molecular sciences.

Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus-Derived Vectors Fosters Dendritic Cell-Mediated T-cell Cross-Priming.

S. Quezada, I. Melero, M. Rodriguez-Ruiz, 2018, Cancer research.

A new generation of vaccines based on alphavirus self-amplifying RNA

C. Smerdou, Noelia Silva-Pilipich, María Cristina Ballesteros-Briones, 2020, Current Opinion in Virology.

Short-Term Local Expression of a PD-L1 Blocking Antibody from a Self-Replicating RNA Vector Induces Potent Antitumor Responses.

J. Prieto, I. Melero, M. Buñuales, 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

Gene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12.

C. Smerdou, María Cristina Ballesteros-Briones, R. Hernández-Alcoceba, 2016, Immunotherapy.

Local delivery of optimized nanobodies targeting the PD-1/PD-L1 axis with a self-amplifying RNA viral vector induces potent antitumor responses.

J. Lasarte, G. González-Sapienza, Ana Igea, 2023, Cancer letters.

Gene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12.

C. Smerdou, María Cristina Ballesteros-Briones, R. Hernández-Alcoceba, 2016, Immunotherapy.

Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus-Derived Vectors Fosters Dendritic Cell-Mediated T-cell Cross-Priming.

S. Quezada, I. Melero, M. Rodriguez-Ruiz, 2018, Cancer research.